From: Rationale, design and objectives of ARegPKD, a European ARPKD registry study
Synopsis of data obtained in ARegPKD | |
---|---|
Basic data | |
a | Basic information with date of birth, sex, onset of symptoms and initial visit at doctor |
b | Family history |
c | Pre- and perinatal period/infancy |
d | Initial diagnosis |
e | Genetics |
Initial visit/yearly follow-up visits | |
a | Patient’s status – baseline evaluation (e.g. body-measurements, participation in studies, availability of biosamples) |
b | Renal status including symptoms, radiological findings, biopsy results |
c | Extrarenal status regarding liver (symptoms, radiological findings, biopsy results) and other organs (spleen, cardiovascular system, central nervous system, eyes, lungs, bones, blood) |
d | Laboratory values |
e | Medications with start and end date, dose |
f | Therapy including renal replacement therapy, surgical procedures and other procedures |
g | Further developments with inclusion of user-defined comments |